Brain Diseases  >>  sodium phenylbutyrate  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
sodium phenylbutyrate / Generic mfg.
NCT00551200: Dose-Escalation Safety Study of HPN-100 to Treat Urea Cycle Disorders

Completed
2
14
US
HPN-100, BUPHENYL®, Sodium Phenylbutyrate, NaPBA
Horizon Pharma Ireland, Ltd., Dublin Ireland
Urea Cycle Disorders
07/08
12/08
NCT00947544: Study of the Safety and Tolerability of HPN-100 Compared to Sodium Phenylbutyrate in Children With Urea Cycle Disorders

Completed
2
17
US, Canada
HPN-100, GT4P, Glyceryl tri-(4-phenylbutyrate), NaPBA
Horizon Pharma Ireland, Ltd., Dublin Ireland
Urea Cycle Disorders
08/11
08/11

Download Options